YOGESH M. AGRAWAL has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Yogesh M. Agrawal, a promoter of Ajanta Pharma, has filed a disclosure with the stock exchange under Regulation 31(4) of SEBI's Takeover Regulations. This regulation applies to shareholders holding more than 25% of a company's shares and requires them to declare that they will not sell their shares without prior shareholder approval through a special resolution. The filing is a routine compliance submission confirming his status as a substantial stakeholder of the company. No details about any actual share sale, pledge, or change in holding are mentioned in the announcement.
This is a procedural compliance filing and is unlikely to have any material impact on the stock price. It simply confirms that the promoter continues to hold a significant stake (above 25%) and is bound by the no-sale restriction unless shareholders approve.